Visium Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-51,419
Closed -$873K 1336
2014
Q4
$873K Sell
51,419
-599,381
-92% -$8.43M 0.01% 569
2014
Q3
$7.76M Buy
+650,800
New +$4.44M 0.11% 184

Visium Asset Management's AVNR Position: Q1 2015 in Review

Visium Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 51,419 shares — an estimated $873K sold.

Visium Asset Management first reported a position in AVNR in Q3 2014 and held it in 2 quarters. The position peaked at $7.76M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Visium Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Visium Asset Management sold 51,419 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $873K.
  • Visium Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 2 quarters.
  • Visium Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $7.76M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.